A KeyHealth PMB ruling requires the medical scheme to fund a teenager’s rare blood disorder treatment in full, without membership conditions. The Council for Medical Schemes (CMS) appeals committee issued its decision on 29 October. However, KeyHealth has notified the registrar that it intends to appeal to the CMS appeals board. The case involves a 15-year-old with paroxysmal nocturnal haemoglobinuria,…
KeyHealth Ordered to Fully Fund Teenager’s Rare-Disease Treatment
